Siemens finds itself at a fascinating crossroads. While the industrial conglomerate reports record-breaking operational metrics and advances ambitious artificial intelligence initiatives, its share price tells a story of investor caution. The equity currently trades approximately 14% below its peak from January, highlighting a disconnect between fundamental strength and market sentiment.
Strategic Shifts and Leadership Changes
A significant source of the prevailing market uncertainty stems from corporate transformation, not financial performance. Siemens has announced its intention to distribute roughly 30% of its stake in Siemens Healthineers directly to its shareholders. This move would reclassify the medical technology giant as a financial investment on Siemens’ books. Specifics regarding the timeline and tax structure are pending, with CEO Roland Busch expected to provide details in the second calendar quarter. Until then, the transaction remains a key unknown.
This strategic pivot coincides with a change in financial leadership. After more than a decade as Chief Financial Officer, Ralf Thomas will pass the role to Veronika Bienert. Thomas is formally stepping down from the managing board on May 13, after which he will assume an advisory position. The exact timing for the handover is still being finalized.
A Quarter of Record Fundamentals
The company’s first-quarter results for fiscal 2026 underscore its operational vigor. Revenue advanced by 8% to €19.1 billion, while new orders climbed 10% to €21.4 billion. The order backlog reached an unprecedented €120 billion. The data center business was a particular standout, with revenue surging 35%—a clear reflection of sustained, robust demand for cloud infrastructure, primarily in the United States.
Despite these strong figures, the share price of around €222 sits notably below its 50-day moving average of €248. This technical indicator suggests the market is adopting a wait-and-see approach.
Concrete Steps in AI and Automation
Siemens is aggressively shaping its identity as an AI-driven industrial leader. On March 11, the company signed a Memorandum of Understanding with the U.S. Department of Energy to support the Genesis Mission, a federal initiative aimed at modernizing scientific infrastructure. Unlike fellow signatories such as OpenAI or Google, Siemens’ focus lies in integrating AI into engineering, validation, and operational workflows, leveraging digital twins and physics-based simulation.
Internal transformation is equally vigorous. In partnership with NVIDIA, Siemens is working to evolve its Electronics Factory in Erlangen into the world’s first fully AI-controlled production site by 2026. Its Amberg location is slated to follow by 2030, supported by an investment of approximately €200 million. These initiatives are complemented by an ongoing share buyback program. The company has already deployed €4.4 billion, with plans to retire 18 million of its own shares in March.
All eyes are now on the Q2 results scheduled for May 13. The report will reveal whether the core business continues to more than offset the costs of this broad transformation and whether CEO Busch can provide the awaited clarity on the Healthineers transaction. The combination of these factors will likely be decisive for the stock’s ability to reclaim its ground from the start of the year.